Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg. 1987;19(4):330-333.

Altenkirch H, Stoltenburg-Didinger G, Koeppel C. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain. Toxicology. 1988;49(1):25-34.

Amitai Y, Almog S, Singer R, Hammer R, Bentur Y, Danon YL. Atropine poisoning in children during the Persian Gulf crisis: a national survey in Israel. JAMA. 1992;268(5):630-632.

Andreassi L. Chemical warfare and the skin. Int J Dermatol. 1991;30(4):252-253.

Anzueto A, de Lemos RA, Seidenfeld J, et al. Acute inhalation toxicity of soman and sarin in baboons. Fundam Appl Toxicol. 1990;14:676-687.

Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg. 1984(suppl):254-259.

Barnaby F. Iran-Iraq war: the use of chemical weapons against the Kurds. Ambio. 1988;17(6):407-408.

Barranco VP. Mustard gas and the dermatologist. Int J Dermatol. 1991;30(10):684-686.

Black RM, Clark RJ, Read RW, Reid MTJ. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products. J Chromatogr. 1994;662:301-321.

Black RM, Read RW. Methods for the analysis of thiodiglycol sulphoxide, a metabolite of sulphur mustard, in urine using gas chromatography-mass spectrometry. J Chromatogr. 1991;558(2):393-404.

Blodi FC. Mustard gas keratopathy. Int Ophthalmol Clin. 1971;11(3):1-13.

Bondy SC. Especial considerations for neurotoxicological research. Crit Rev Toxicol. 1985;14(4):381-402.

Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med. 1992;21(3):303-308.

Bruce J. Briefing: playing hide and seek with Saddam. Jane's Defence Weekly. January 3, 1996: 17-19.

Cancio LC. Chemical casualty decontamination by medical platoons in the 82nd Airborne Division. Mil Med. 1993;158(1):1-5.

Charles D, Nowak R. The poisonous power of chemical warfare. New Scientist. August 25, 1990:22-24.

Clarkson TW. Metal toxicity in the central nervous system. Environ Health Perspect. 1987;75:59-64.

Crowell JA, Parker RM, Bucci TJ, Dacre JC. Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol. 1989;4:15-20.

Das Gupta S, Bass KN, Warnick JE. Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats. Toxicol Appl Pharmacol. 1989;99:28-36.

Dienstbier Z. Late effects of use of nuclear and certain chemical weapons in man. Med War. 1985;1(1):25-30.

Duffy B. The guns of August. US News World Rep. August 20, 1990:18-26.

Dunn MA, Sidell FR. Progress in medical defense against nerve agents. JAMA. 1989;262(5):649-652.

Gazzard MF, Thomas DP. A comparative study of central visual field changes induced by sarin vapor and physostigmine eye drops. Exp Eye Res. 1975;20:15-21.

Goldman M, Dacre JC. Lewisite: its chemistry, toxicology, and biological effects. Rev Environ Contam Toxicol. 1989;110:75-115.

Goldstein BD, Fincher DR, Searle JR. Electrophysiological changes in the primary sensory neuron following subchronic soman and sarin: alterations in sensory receptor function. Toxicol Appl Pharmacol. 1987;91:55-64.

Gupta RC, Patterson GT, Dettbarn WD. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat. Fundam Appl Toxicol. 1991;16:449-458.

Hajgar J. Biological monitoring of exposure to nerve agents. Br J Ind Med. 1992;49:648-653.

Heyndrickx A, De Puydt H, Cordonnier J. Comparative study of two different field tests for the detection of yperite in the atmosphere, applied on biological samples of gased soldiers. Arch Belg. 1984;(suppl):61-68.

Heyndrickx A, Heyndrickx B. Treatment of Iranian soldiers attacked by chemical and microbiological war gases. Riv Tossicol Sper Clin. 1989;19(1-3):3-6.

Heyndrickx A, Sookvanichsilp N, Van Den Heede M. Detection of trichothecene mycotoxins (Yellow Rain) in blood, urine, and faeces of Iranian soldiers treated as victims of a gas attack. Riv Tossicol Sper Clin. 1989;19(1-3):7-11.

Hu H, Cook-Deegan R, Shukri A. The use of chemical weapons. Conducting an investigation using survey epidemiology. JAMA. 1989;262(5):640-643.

Hughes JN, Knight R, Brown RFR, Marrs TC. Effects of experimental sarin intoxication on the morphology of the mouse diaphragm: a light and electron microscopical study. Int J Exp Pathol. 1991;72:195-209.

Husain K, Vijayaraghavan R, Pant SC, Raza SK, Pandey KS. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. J Appl Toxicol. 1993;13:143-145.

Institute of Medicine; Pechura CM, Rall DP, eds. Veterans at Risk: The Health Effects of Mustard Gas and Lewisite. Pechura CM, Rall DP, eds. Washington, DC: National Academy Press; 1993.

Jacob WH, Friedl KE. Drug delivery systems for chemical defense. Army Research, Development, and Acquisition Bulletin. January/February 1990:14-16.

Jenkins RA, Buchanen MV, Merriweather R, Ilgner RH, Gayle TM, Watson AP. Movement of chemical warfare agent stimulants through porous media. J Hazard Mater. 1994;37(2):303-325.

Kadivar H, Adams SC. Treatment of chemical and biological warfare injuries: insights derived from the 1984 Iraqi attack on Majnoon Island. Mil Med. 1991;156(4):171-177.

Kawabuchi M, Cintra WM, Despande SS, Albuquerque EX. Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition. Synapse. 1991;8:218-228.

Klein AK, Nasve ML, Goldman M. The effects of in vitro exposure to the neurotoxin sarin (GB) and soman (GD) on unscheduled DNA synthesis by rat hepatocytes. Toxicol Lett. 1987;38:239-249.

Kodavanti PRS, Mundy WR, Tilson HA, Harry GJ. Effects of selected neuroactive chemicals on calcium transporting systems in rat cerebellum and on survival of cerebellar granule cells. Fundam Appl Toxicol. 1993;21:308-316.

Kolka MA, Stephenson LA, Bruttig SP, et al. Human thermoregulation after atropine and/or pralidoxime administration. Aviat Space Environ Med. 1987;58:545-549.

Koslow EE. Would you go to war wearing this equipment? Armed Forces Journal International. May 1990:55-58.

Kuncl RW, George EB. Toxic neuropathies and myopathies. Curr Opin Neurol. 1993;6(5):695-704.

Little PJ, Scimeca JA, Martin BR. Distribution of [3H] diisopropyl-fluorophosphate, [3H] soman, [3H] sarin and their metabolites in mice brain. Drug Metab Disposition. 1988;16:515-520.

Liu DD, Watanabe HK, Ho IK, Hoskins B. Acute effects of soman, sarin, and tabun on cyclic nucleotide metabolism in rat striatum. J Toxicol Environ Health. 1986;19:23-32.

Liverman CT, Pechura CM, compilers. Health Effects of Mustard Gas and Lewisite: Subject Bibliography. Washington, DC: Institute of Medicine, Division of Health Promotion and Disease Prevention;1992.

Macilain C. Study proves Iraq used nerve gas. Nature. 1993;363:3. News.

Malizia E, Smeriglio M, Milletti M, et al. Acute poisoning with chemical warfare agents: clinical observations on a group of patients and a follow-up after seven years. Riv Tossicol Sper Clin. 1991;21(2-3):73-103.

Maurissen JP. Psychophysical testing in human populations exposed to neurotoxicants. Neurobehav Toxicol Teratol. 1985;7(4):309-317.

Meisenberg BR, Melaragno AJ, Monroy RL. Granulocyte colony stimulating factor (G-CSF) for mustard-induced bone marrow suppression. Mil Med. 1993;158(7):470-474.

Mellor SG, Rice P, Cooper GJ. Vesicant burns. Br J Plast Surg. 1991;44(6):434-437.

Mohamed-Ali H. Late lesions due to poison gas in survivors of the Iraqi poison warfare against the Kurdish people [in German]. Wien Med Wochenschr. 1992;142(1):8-15.

Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol. 1992;128(6):775-780.

Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet. 1995;346:290-293.

Munro NB, Watson AP, Ambrose KR, Griffin GD. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ Health Perspect. 1990;89:205-215.

Murray VS, Volans GN. Management of injuries due to chemical weapons. BMJ. 1991;302(6769):129-130. Editorial.

Mustard gas. IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:181-192.

Newman-Taylor AJ, Morris AJ. Experience with mustard gas casualties. Lancet. 1991;337(8735):242. Letter.

Orma PS, Middleton RK. Aerosolized atropine as an antidote to nerve gas. Ann Pharmacother. 1992;26(7-8):937-938.

Pal T, Griffin GD, Miller GH, Watson AP, Daugherty ML, Vo-Dinh T. Permeation measurements of chemical agent simulants through protective clothing materials. J Hazard Mater. 1993;33(1):123-141.

Pauser G, Aloy A, Carvana M, et al. Lethal intoxication by wargases on Iranian soldiers. Therapeutic interventions on survivors of mustard gas and mycotoxin immersion. Arch Belg. 1984(suppl):341-351.

Pechura CM; from the Institute of Medicine. The health effects of mustard gas and lewisite. JAMA. 1993;269(4):453.

Pour-Jafari H, Moushtaghi AA. Alterations of libido in gased Iranian men. Vet Hum Toxicol. 1992;34(6):547.

Prakash UB. Chemical warfare and bronchoscopy. Chest. 1991;100(6):1486. Editorial.

Prevention and treatment of nerve gas poisoning. Med Lett Drugs Ther. 1990;32:103-105.

Rall DP, Pechura CM. Effects on health of mustard gas. Nature. 1993;366(6454):398-399. Letter.

Reed F. Gas warfare: plenty to worry about. Army Times. September 1990:70.

Rees J, Harper P, Ellis F, Mitchell D. Mustard gas casualties. Lancet. 1991;337(8738):430. Letter.

Rengstorff RH. Accidental exposure to sarin: vision effects. Arch Toxicol. 1985;56:201-203.

Requena L, Requena C, Sanchez M, et al. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol. 1988;19(3):529-536.

Sandelowsky I, Simon GA, Bel P, Barak R, Vincze A. N1-(2-hydroxyethylthioethyl)-4-methyl imidazole (4-met-1-imid-thiodiglycol) in plasma and urine: a novel metabolite following dermal exposure to sulphur mustard. Arch Toxicol. 1992;66(4):296-297.

Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology. 1987;37(2):276-278.

Scicchitano JP. Pentagon says Iraqi chemical threat is real. Army Times. August 20, 1990:16.

Seppalainen AM. Solvents and peripheral neuropathy. Prog Clin Biol Res. 1986;220:247-253.

Sidell FR, Borak J. Chemical warfare agents: II. Nerve agents. Ann Emerg Med. 1992;21(7):865-871.

Silbergeld EK. Understanding risk: the case of dioxin. Scientific American. November/December 1995: 48-57.

Singer AW, Jaax NK, Graham JS, McLeod CG Jr. Cardiomyopathy in soman and sarin intoxicated rats. Toxicol Lett. 1987;36:243-249.

Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol. 1991;127(8):1207-1213.

Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. Journal of the American Academy of Dermatology. 1995;32(5):765-776.

Sohrabpour H. Clinical manifestations of chemical agents on Iranian combatants during Iran-Iraq conflict. Arch Belg. 1984;(suppl):291-297.

Soldiers as experimental animals. Nature. 1993;361(6412):479. Editorial.

Taher AA. Cleft lip and palate in Tehran. Cleft Palate Craniofac J. 1992;29(1):15-16.

Thomas TL, Kang HK. Mortality and morbidity among Army Chemical Corps Vietnam veterans: a preliminary report. Am J Ind Med. 1990;18(6):665-674.

Tice J. Liquid logistics imperative in the desert. Army Times. August 20, 1990:22.

Tucker J. Saddam's toxic plot: did Iraqi military planners hatch a secret scheme to debilitate our troops with low levels of chemical and biological weapons? The American Legion. May 1996;26-27, 50-51.

Turque B, Glick D, Barry J. The specter of Iraq's poison gas. Newsweek. August 20, 1990:26.

van den Bercken J. The action of allethrin on the peripheral nervous system of the frog. Pestic Sci. 1977;8:692-699.

Verity MA. Neurotoxins and environmental poisons. Curr Opin Neurol Neurosurg. 1992;5(3):401-405.

Warnick JE, Deshpande SB, Yang QZ, Das Gupta S. Biphasic action of sarin on monosynaptic reflex in the neonatal rat spinal cord in vitro. Arch Toxicol. 1993;67:302-306.

Watson R. Battle ready. Newsweek. August 20, 1990:20-25.

Watson AP, Ambrose KR, Griffin GD, Leffingwell SS, Munro NB, Waters LC. Health effects of warfare agent exposure: implications for stockpile disposal. Environ Prof. 1989;11(4):335-353.

Watson AP, Jones TD, Adams JD. Relative potency estimates of acceptable residues and reentry intervals after nerve agent release. Ecotoxicol Environ Safety. 1992;23(3):328-342.

Watson AP, Jones TD, Griffin GD. Sulfur mustard as a carcinogen: application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regul Toxicol Pharmacol. 1989;10(1):1-25.

Wils ER, Hulst AG, de Jong AL, Verweij A, Boter HL. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol. 1985;9(6):254-257.

Wils ER, Hulst AG, van Laar J. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas, Part II. J Anal Toxicol. 1988;12(1):15-19.

Yanagisawa N, ed. Report for toxic gas attack in Matsumoto. Matsumoto Local Medical Council. Matsumoto, Japan: 1995.

Table of Contents